News Hub | News Direct

Colon Cancer Creeping Into Younger Adults - New R&D Uncovers Early Signs

MarketJar

Spots of blood after bowel movements, stomach aches, and protracted episodes of diarrhea may be symptoms of early-onset colorectal cancer, which is increasingly diagnosed in young adults who are ineligible for colonoscopies. The most concerning early indicator of colon cancer is rectal bleeding, which is taboo to talk about outside of the bathroom. According to Dr. Matthew Kalady in a recent NBC News article, head of the division of colon and rectal surgery at the Ohio State University Comprehensive Cancer Center, "It can be difficult or embarrassing to talk about." However, he added, "the reality is that everyone deals with something like this," and it's crucial to know what's typical and what isn't. 5,075 people with early-onset colorectal cancer were included in the new study from Washington University School of Medicine in St. Louis, which was published Thursday in the Journal of the National Cancer Institute. The intention was to identify symptoms that could serve as warning signs for colorectal cancer, a condition that has been on the rise in younger individuals in recent years but whose alarmingly high rate of late-stage diagnosis warrants concern. The percentage of colorectal cancer diagnoses involving individuals under the age of 55 quadrupled from 1995 to 2019, from 11% to 20%, according to the American Cancer Society. Up to two years before a colon cancer diagnosis, the current study identified four different signals: Abdominal pain. Rectal bleeding. Ongoing diarrhea. Anemia due to iron deficiency. At least one of the symptoms, which could have started up to two years prior to a diagnosis, was experienced by participants. However, a colonoscopy is only advised at or after the age of 45. This implies that patients may have symptoms for a long time before seeking medical attention or receiving a colon cancer diagnosis, which is treatable if discovered early. The study's lead author, Dr. Cassandra Fritz, an assistant professor of medicine in the division of gastrointestinal at the Washington University School of Medicine, said, "As patients, we kind of brush these things away." At least one of such symptoms was present in nearly half of the study subjects three months before their diagnoses. Additional symptoms increased the likelihood of a cancer diagnosis. The study, according to fellow author Yin Cao, an associate professor of surgery in the department of public health sciences at Washington University School of Medicine, indicates an "alarming problem" for young adults and the medical professionals who treat them. “Young folks need to be aware of these indicators”, Cao stated in an interview, and “this is the message we are making loud and clear.” Committed to Saving Lives by Improving At-Home Cancer Detection A non-invasive, quick, easy, and accurate colorectal detection test is available from Mainz Biomed (NASDAQ:MYNZ). Stool tests are more accurate than blood tests and may be performed in the comfort of your own home, making them a more practical choice. In addition to early colon cancer detection, on May 10th Mainz Biomed announced a partnership with Microba Life Sciences for the Development of PancAlert. The combination of DNA and microbiome biomarkers has the potential to improve the technical profile of a novel pancreatic cancer screening test. A collaborative research initiative is underway to identify disease-specific microbiome biomarkers. With ColoAlert already out in the market, PancAlert looks to be another monumental tool helping savr lives from pancreatic cancer. The company's core product, ColoAlert, is an at-home colorectal cancer (CRC) screening kit with high sensitivity and specificity. Patients are given a basic kit that includes directions, a stool collector, and mailing instructions so they can mail the kit back to their local lab for testing and results. This non-invasive test can identify malignancies earlier than fecal occult blood tests (FOBT) by analyzing tumor DNA. ColoAlert, a stool test that uses PCR technology, finds more cases of colorectal cancer than traditional stool tests and enables early detection. Through a network of top independent laboratories, corporate health initiatives, and direct sales, this screening test is CE marked and is commercially available in a number of European countries. To receive commercial approval in the US, ColoAlert will be examined in the FDA-registered trial "ReconAAsense." Once licensed in the United States, the Company's commercial objective is to build scalable distribution across the nation through a cooperative partner program with local and national laboratory service providers. For the processing of the ColoAlert PCR test kit, Mainz Biomed (NASDAQ:MYNZ) has expanded its network of lab partners to include Eurofins GeLaMed. A division of the global laboratory corporation Eurofins Scientific, which does 450 million tests annually and employs over 61,000 people in 61 nations, is Eurofins GeLaMed. Germany is home to four of its locations. Eurofins GeLaMed offers cutting-edge diagnostics in human genetics, medical microbiology, laboratory medicine, and molecular diagnostics across eleven medical specialties. The more than 500 staff of GeLaMed process more than 15,000 orders daily and offer more than 2,000 analytical procedures from their portfolios in laboratory medicine and microbiology, all under the supervision of medical specialists. Marcus Cholewa, Director of Clinical Diagnostics for Eurofins Business Line in DACH, expressed enthusiasm for the partnership between Mainz Biomed and Eurofins GeLaMed because Eurofins consistently offers the highest levels of quality, customer service, and the most thorough testing methodologies. Additionally, he said that Eurofins has a track record of offering innovative and high-quality diagnostic testing solutions, and that by collaborating, they could be able to detect colorectal cancer (CRC) and give patients individualized information to help them manage their health. In order to raise awareness of the importance of early screening for CRC identification and prevention, Mainz Biomed (NASDAQ:MYNZ) will support physician and patient education programs during March Colorectal Cancer Awareness Month and Eurofins GeLaMed will provide ColoAlert at its testing locations. Additionally, Mainz Biomed has expanded its network of lab partners across Europe and a few overseas markets by including the Instituto de Microecologia in Madrid. For more than 60 years, the Instituto de Microecologia has been a leader in the study of the microbiota and food sensitivity, emphasizing the importance of intestinal health through microbiological investigation, microbiota profile diagnosis, and specialized health indicators. The company's ongoing expansion in Europe may be seen in Mainz Biomed's entry into the market and commercialization in Spain and Portugal. Visit this link to learn more about Mainz Biomed (NASDAQ:MYNZ) and its initiatives. Disclaimer 1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on research and understanding of the sector. 2) The Article was issued on behalf of and sponsored by, Mainz Biomed NV. Market Jar Media Inc. has or expects to receive from Mainz Biomed NV’s Digital Marketing Agency of Record (Native Ads Inc.) seventy three thousand three hundred forty USD for 17 days (13 business days). 3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. Market Jar has not independently verified or otherwise investigated all such information. None of Market Jar or any of their respective affiliates, guarantee the accuracy or completeness of any such information. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy. 4) The Article does not constitute investment advice. All investments carry risk and each reader is encouraged to consult with his or her individual financial professional. Any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.'s terms of use and full legal disclaimer as set forth here. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on pressreach.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on pressreach.com. 5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article. 6) This document contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, (collectively, “forward-looking statements”), which reflect management's expectations regarding Mainz Biomed NV’s future growth, future business plans and opportunities, expected activities, and other statements about future events, results or performance. Wherever possible, words such as “predicts”, “projects”, “targets”, “plans”, “expects”, “does not expect”, “budget”, “scheduled”, “estimates”, “forecasts”, “anticipate” or “does not anticipate”, “believe”, “intend” and similar expressions or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. These forward-looking statements include, among other things, statements relating to: (a) revenue generating potential with respect to Mainz Biomed NV’s industry; (b) market opportunity; (c) Mainz Biomed NV’s business plans and strategies; (d) services that Mainz Biomed NV intends to offer; (e) Mainz Biomed NV’s milestone projections and targets; (f) Mainz Biomed NV’s expectations regarding receipt of approval for regulatory applications; (g) Mainz Biomed NV’s intentions to expand into other jurisdictions including the timeline expectations relating to those expansion plans; and (h) Mainz Biomed NV’s expectations with regarding its ability to deliver shareholder value. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: (a) the ability to raise any necessary additional capital on reasonable terms to execute Mainz Biomed NV’s business plan; (b) that general business and economic conditions will not change in a material adverse manner; (c) Mainz Biomed NV’s ability to procure equipment and operating supplies in sufficient quantities and on a timely basis; (d) Mainz Biomed NV’s ability to enter into contractual arrangements with additional Pharmacies; (e) the accuracy of budgeted costs and expenditures; (f) Mainz Biomed NV’s ability to attract and retain skilled personnel; (g) political and regulatory stability; (h) the receipt of governmental, regulatory and third-party approvals, licenses and permits on favorable terms; (i) changes in applicable legislation; (j) stability in financial and capital markets; and (k) expectations regarding the level of disruption to as a result of CV-19. Such forward-looking information involves a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of Mainz Biomed NV to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: (a) Mainz Biomed NV’s operations could be adversely affected by possible future government legislation, policies and controls or by changes in applicable laws and regulations; (b) public health crises such as CV-19 may adversely impact Mainz Biomed NV’s business; (c) the volatility of global capital markets; (d) political instability and changes to the regulations governing Mainz Biomed NV’s business operations (e) Mainz Biomed NV may be unable to implement its growth strategy; and (f) increased competition. Except as required by law, Mainz Biomed NV undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither does Mainz Biomed NV nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this document. Neither Mainz Biomed NV nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this document by you or any of your representatives or for omissions from the information in this document. 7) Any graphs, tables or other information demonstrating the historical performance or current or historical attributes of Mainz Biomed NV or any other entity contained in this document are intended only to illustrate historical performance or current or historical attributes of Mainz Biomed NV or such entities and are not necessarily indicative of future performance of Mainz Biomed NV or such entities. Contact Details James Young +1 800-340-9767 campaigns@pressreach.com Company Website https://pressreach.com

May 10, 2023 09:00 AM Eastern Daylight Time

Image

Introducing Mother Science: A Revolutionary Biotech Skincare Brand Bringing Patented Ingredient Malassezin to Market with Molecular Hero Serum

Mother Science

Introducing Mother Science: A Revolutionary Biotech Skincare Brand Bringing Patented Ingredient Malassezin to Market with Molecular Hero Serum Mother Science is Engineering the Next Generation of Skincare Through Cutting-Edge Science, Technology, & Innovation Mother Science, a revolutionary biotech skincare brand, launches today with its first proprietary product - Molecular Hero Serum - that harnesses the power of Malassezin, a breakthrough, patented and first-to-market ingredient that is a 10x more powerful antioxidant than Vitamin C. This molecule, which naturally occurs on skin, has the unique ability to target hyperpigmentation, improve the skin’s moisture barrier, and provide potent antioxidant protection for powerful benefits without irritation. After extensive laboratory studies and two clinical trials, Mother Science is the first brand in skincare to use this novel molecule. The serendipitous discovery of Malassezin was fueled by the curiosity of co-founders and husband-wife duo, Mike Einziger, founding guitarist of Incubus, and renowned violinist, Ann Marie Simpson-Einziger. In addition to their passion for music, Mike and Ann Marie have always been enthralled by science. Mike studied the history of science at Harvard and Ann Marie studied biology at The University of Virginia and later taught high school physics and chemistry. In 2016 while on tour, Ann Marie developed a harmless skin condition that caused lightened patches of skin on her back. She had a hypothesis: could whatever caused them be used to intentionally reduce the look of dark spots on her face. The couple assembled a team of leading scientists, and together, over the course of six years, uncovered the power of Malassezin, which led to the inception of Mother Science. Mother Science’s first product, Molecular Hero Serum, features Malassezin. This first-of-its-kind serum dramatically reduces the appearance of dark spots and sun damage, for an overall brighter, smoother, more youthful-looking complexion. The clinically-tested serum delivers proven results starting in just two weeks and can be used AM and PM. CLINICAL RESULTS In just 4 weeks*: 100% of participants had a reduction in the appearance of dark spots. 100% saw brighter, smoother skin. 100% had a visible improvement in lines and wrinkles. 94% said their skin looked more youthful. “True molecular innovation is rare, and discovering Malassezin required a mix of luck, curiosity, scientific rigor, and passion,” said Ann Marie Simpson-Einziger, Co-Founder of Mother Science. “I’ve always called myself a ‘citizen scientist,’ and the Mother Science brand embodies this ethos of entrepreneurship, curiosity, continuous learning, and innovation,” added Mike Einziger, Co-Founder of Mother Science. “With over six years of rigorous testing and research, we are thrilled to launch the next generation biotech skincare company, and we’re just getting started.” Mike and Ann Marie brought on Jessica Goldin as Mother Science’s CEO and Co-Founder to build the brand and shepherd its go-to-market strategy. Goldin is a 20-year beauty industry veteran who previously served as the founding CEO of Shani Darden Skin Care and held various leadership and executive marketing roles at Beautycounter, Murad, Clinique, and Victoria’s Secret Beauty. Mother Science’s team also includes Dr. Pearl Grimes, the brand’s Chief Dermatologist, a globally recognized expert and leading authority in hyperpigmentation. Dr. Grimes has spent the past six years leading extensive scientific studies on Malassezin. "Consumers are becoming more and more interested in science-based skincare, " said Jessica Goldin, Mother Science’s CEO and Co-Founder. "As a biotech beauty brand with a proprietary, novel ingredient, we are excited to introduce a highly efficacious serum based on a new approach to treating dark spots and sun damage." Mother Science’s seed round was led by Female Founders Fund with participation from defy.vc, Founders Fund, KarpReilly, H Venture Partners, NewBound Ventures, BFG Partners, Tuesday Capital, Olive Capital, Liquid 2 Ventures, and Hawktail. Other investors include Drew Houston, Founder and CEO of Dropbox, John Paul DeJoria, Co-Founder of Paul Mitchell, Hedi Gores, Co-Founder of Pressed Juicery, Jared Smith, Co-Founder of Qualtrics, Toni Ko, Founder of NYX, Carlos Cashman, Co-Founder of Thrasio, Cyan Banister, Sabrina Hahn, and Molly DeWolf Swenson. “We are thrilled to support Mother Science in their mission to bring an innovative, science-based solution to the market that addresses one of the most prevalent skincare concerns: dark spots,” said Anu Duggal, Partner, Female Founders Fund. “Today's consumers are increasingly focused on skincare efficacy, and the clinical results of the Molecular Hero Serum are very promising in this regard. With its unique formulation and demonstrated effectiveness, we believe that this product has the potential to make a significant impact in the skincare industry and help people feel more confident in their skin.” Mother Science’s Molecular Hero Serum ($89) is available for purchase starting today at motherscience.com. For additional information, please visit Mother Science’s website, and follow @motherscience on Instagram. *Based on a clinical study using instrumentation, VISIA photography, expert grading, and consumer perception. Participants used the serum twice a day. ### About Mother Science Mother Science is a revolutionary biotech beauty brand creating next-generation skincare solutions. The brand is pushing the boundaries of skincare formulations with cutting-edge science, beginning with its never-before-used ingredient, Malassezin. Born out of curiosity and a passion for science, Mother Science aims to build a community inspired by learning and innovation. The brand is founded by renowned musicians, Mike Einziger and Ann Marie Simpson-Einziger. Contact Details Powers PR Kylee Kaetzel kylee@powers-pr.com

May 09, 2023 09:03 AM Eastern Daylight Time

Image

BettingLadies.com Launches Sports Betting Industry’s First Affiliate, News and Content Site For All Sports, For Women - By Women

BettingLadies.com

BettingLadies.com, the first sports betting affiliate and content site for all sports written by women, for women, today announced it has officially launched its public-facing site. All content on the site is written, created and produced by women content creators to explicitly provide sports betting news, information, odds and statistics for women bettors of all skill levels. While most sites which target the women-bettor demographic segment their offering by exclusively discussing women’s sports, BettingLadies.com differentiates itself through the discussion of both women’s and men’s sports. This mixed approach to female-targeted content enables bettors to participate in and enjoy wagering opportunities around dominant leagues such as the NBA, NHL and MLB, while also embracing the emerging market of women’s sports betting. “The genesis of BettingLadies.com is about making sports betting more accessible for women. I looked for content to help educate myself as a bettor, but found the majority of resources were clearly created to be consumed by a male audience,” said Val C. Martinez, CEO and founder of BettingLadies.com. “Multiple studies have found that nearly a third of the betting market is women, however the opportunities for female-centric content have been limited. While there are women content creators in the market, I strategically saw whitespace and wanted to create a new space where bettors could consume content from like-minded female sports fans, as well as build a platform where female creators can find a voice in the emerging sports betting market.” Martinez brings more than 20-years experience as a banker and financial executive, leading large business groups in major financial institutions, to her role as founder of BettingLandies.com. In addition to daily news from the sports world and daily betting lines, BettingLadies.com currently hosts the following signature elements: BettingLadies.com Community - Sign up and meet, interact and discuss betting with like-minded women. Lady Locks - Daily videos provide insights and betting information on the day’s biggest sporting events. Betting Guides - Educational videos, tutorials and how-to’s for all betting skills from beginners to the advanced. Tarot Reading - A fun free-to-play game for users to get their fortune on different sports betting experiences. The site’s most noted content creator is a professional wrestler and sports broadcast talent Danielle Kamela. In addition to writing for BettingLadies.com, Kamela creates the site’s signature digital asset, the daily “Lady Locks” series, which posts to Instagram, Facebook and Twitter. “What drew me to working with BettingLadies.com was Val’s vision to create an approachable, judgement free and inclusive community, built on educating and supporting the growth of women bettors across the country,” Kamela said. “As a fan and bettor of all sports, Lady Locks provides me the opportunity to be flexible in the content I create, moving seamlessly from NBA to MLB games and NFL games in the fall. I’m excited about the future of this site and giving a voice to women bettors.” In addition to Kamela, BettingLadies.com has plans to expand to more than a dozen featured personalities in the coming months. “Beyond the launch, our goal is to evolve BettingLadies.com to be synonymous with the betting experience for women. We’ll soon begin creating in-person regional betting events based on the growth of our community,” said Martinez. “We’re continually looking for new affiliate partners, as well as voices and creators, to scale and expand our content to new mediums, social platforms and sports. As a true first mover in this category, we see nothing but potential for the future of women sports bettors.” To learn more about the site and to sign up for the BettingLadies.com betting community, please visit BettingLadies.com. ABOUT BETTINGLADIES.COM BettingLadies.com is the first sports betting affiliate and content site written by women, for women. Founded in 2022, the site offers sports betting news, information, odds and statistics for women bettors of all skill levels, written and produced from a woman’s perspective. For more information and content, visit BettingLadies.com on Instagram, Facebook and Twitter. Contact Details Sterling Randle srandle@hotpaperlantern.com

May 09, 2023 09:01 AM Eastern Daylight Time

NUTRACOLLAGEN® INTRODUCES NEW SPECIALTY VARIETIES OF THEIR POPULAR COLLAGEN COFFEE

NutraCollagen

Grand Rapids, MI based Advanced Protein Technology, which has been in the collagen business since 2004 introduces new buzz worthy variations of its widely popular classic; COLLAGEN COFFEE with three new incredibly nutritious and delicious flavors; Salted Caramel, Chai Latte, and Mocha Hazelnut under the NutraCollagen ® brand. The NutraCollagen ® brand first introduced the world to Collagen Coffee in 2017, when the growing trend of adding collagen to coffee as a “health & beauty” type of creamer first began as a trend. Collagen’s benefits, like supporting healthy hair, skin, nails, joints, and bones are best met when consumed daily, and what better way to work that consumption into a routine than to combine it with that daily cup (or two) of coffee. Coffee, of course has been proven to have several health benefits of its own. Nothing made better sense at the time than pairing this duo of superfood together. The idea seemed obvious to the team at NutraCollagen ® and the first premixed Collagen Coffee was born. Premium, real Columbian Coffee, micro ground and instantized, then blended with Hydrolyzed Collagen Peptides derived from grass-fed bovine. To make this Collagen Coffee beauty blend even more of an ultimate boost for health, wellness, and pick-me-up energy, MCT from coconut oil was added to provide a source of healthy fats that act as an instant source of energy for the body and the brain. Easy-to-use, all of the Collagen Coffee flavor varieties are instantized to prepare effortlessly with hot water without clumping, or simply to infuse collagen into your coffee, or add to any recipe or beverage that you may want to have a coffee flavor and nutritional boost. Also great for refreshing cold shakes and smoothies! Collagen Coffee can also be used to make ice cream, sauces, creamers, cookies, cakes, etc. There is no limit to what you can make! Each COLLAGEN COFFEE smooth and creamy blend has been scientifically crafted to be well-balanced with the highest-quality collagen peptides and a rich blend of real coffee to come out perfectly light and creamy. One serving of Collagen Coffee provides 10-11g of Premium Protein with 11-12g of Collagen Peptides from grass fed bovine. The formulas range from 60-90 calories, contain either 0g to 1g Sugar, are non-GMO, Gluten-free and support KETO and low-carb diets. Best of all, real coffee is used in the COLLAGEN COFFEE blends, naturally providing 40mg of caffeine. Enough to give a much-needed lift without an unwanted lift-off! To find out more about what’s brewing, visit www.collagencoffee.com NUTRACOLLAGEN® brand of collagen products are formulated, manufactured, and distributed by Grand Rapids, Michigan based Advanced Protein Technology, LLC. Dedicated to delivering superior nutritional ingredients with the highest quality for the best price, producing all products while strictly adhering to HACCP, ISO, and GMP standards. Dedicated, in-house technicians have been globally sourcing ingredients and raw materials for over 20 years in the Food & Beverage, Nutraceutical, and Cosmetic industries. Experience and knowledge are the cornerstone of NutraCollagen®, with a business model built on integrity. Contact Details customer@nutracollagen.com J Spingola +1 616-288-0068 jspingola@nutracollagen.com

May 08, 2023 05:00 PM Eastern Daylight Time

Image

Berkshire Hathaway Shareholder to Criticize Warren Buffett and Bill Gates for Politicized Philanthropy

National Legal & Policy Center

National Legal and Policy Center (NLPC) is the sponsor of a Berkshire Hathaway shareholder proposal to separate the roles of Chairman and CEO. On April 21, we filed a proxy memo in support of our resolution, explaining why we believe the succession plan is inadequate and that the company should be less identified with Warren Buffett’s politics. Here is the statement NLPC Chairman Peter Flaherty plans to make at the Berkshire annual meeting on Saturday, April 6 in Omaha, Nebraska: I am Peter Flaherty, Chairman of the National Legal and Policy Center. If we had an independent chair, the Company would be less identified with Mr. Buffett’s political activities. He’s donated more than $100 billion to the Bill and Melinda Gates Foundation. As Bill Gates explained when the couple was still together, “ although the foundation bears our names, basically half our resources have come from Warren Buffett.” If “woke” culture is a disease, then philanthropy is the virus. The Gates Foundation bankrolls the teaching of Critical Race Theory around the country, including that math is inherently racist. The Gates Foundation offers a Gender Identity Toolbox, which asserts that gender is the result of “socially and culturally constructed ideas.” This is a lie. Gender is not a cultural construct. It is a genetic and biological fact. We know how much Bill Gates cares about children. He met and traveled with Jeffrey Epstein MANY times AFTER Epstein was convicted of sex crimes. The Gates Foundation had a huge influence over the COVID response fiasco. Bill Gates defended China’s COVID policies and still discounts the possibility that the virus originated from a lab, even though U.S. intelligence agencies disagree. The Gates Foundation may be the largest single donor to the “dark money” machine known as Arabella Associates which funds causes like defunding the police that are making American cities unlivable. Money goes, too, to groups conducting threatening and vulgar protests at their homes of Supreme Court Justices. Mr. Buffett has quietly funneled more than $4 billion to groups supporting abortion on demand through the Susan Thompson Buffett Foundation. That’s $4 billion, with a B. Advocacy disguised as philanthropy. Bill Gates has lamented political polarization and even worried aloud about a civil war. But it is billionaires who are funding the most shrill and extreme activists who are tearing our country apart. Ironically, Mr. Buffett has pointed out that corporate executives can make a lot of people mad when they insert themselves into controversy. Anheuser-Busch is finding that out. It cannot renounce its Dylan Mulvaney transgender promotion because it is handcuffed by its longtime support for activists who would turn on them in a minute. Anheuser-Busch gets a perfect grade on the Human Rights Campaign scorecard, as do Berkshire portfolio companies like Coca-Cola, Bank of America, and Apple. Bank of America and Apple help bankroll this group, which wants biological men to compete in women’s sports. Worse, it is currently pressuring state legislatures to allow sex change operations on children, and to keep their parents out of the decision. Let’s revisit Coca-Cola, which I discussed at last year’s meeting. CEO James Quincey, a British citizen, tried to kill Georgia’s voter integrity law in 2021 by making inaccurate and inflammatory statements about it. That’s the law that President Biden called “Jim Crow 2.0,” and which prompted Major League Baseball to move the All-Star game out of Atlanta. Mr. Buffett jumped on the bandwagon, too, by signing a statement by corporate leaders suggesting that Republicans seek to restrict ballot access based on race. Two years later, we can now evaluate that accusation. Last year, an election was held in Georgia. Turnout was record breaking. According to an independent poll, 99% of voters said they had “no problem” casting ballots. 92% said the new law either had no impact on their ability to vote or made it easier. James Quincey was wrong, and Mr. Buffett, so were you. ### To schedule an interview with Peter Flaherty, please contact Dan Rene at drene@nlpc.org or Jackie Jones at jackie@truthpr.com Founded in 1991, NLPC promotes ethics in public life and government accountability through research, investigation, education, and legal action. Contact Details National Legal and Policy Center Dan Rene +1 202-329-8357 drene@nlpc.org Company Website http://www.nlpc.org

May 05, 2023 01:00 PM Eastern Daylight Time

ALT Sports Data Wins Third Annual Ifrah Pitch Competition

ALT Sports Data

ALT Sports Data, the leading source of official and unofficial alternative sports trading data unlocking millions of participatory fans and potential bettors for sportsbook operators, media platforms and event producers, has been named the winner of the third annual Ifrah Pitch Competition. Ifrah Law, the leading global law firm at the intersection of interactive gaming and government regulation, sponsors the competition for ascending companies within the U.S. betting and gaming industry to showcase new developments and innovative products to market leaders at the EGR North American Spring Briefing. With the win, ALT Sports Data received a monetary prize as well as strategic legal consultation from Ifrah Law. ALT Sports Data’s product offering serves as a key demand generator for sportsbook partners, providing operators the opportunity to supply more than one billion global alternative sports fans with the opportunity to engage in regulated betting activities. The proprietary managed trading platform supplies real-time dynamic trading data from a portfolio of underserved alternative sports. A full wagering lifecycle for all covered events is included, as pre-match and live odds services generate independent, algorithm-driven betting markets. “Alternative sports have long been overlooked by the sports betting industry, despite a unique opportunity to cost-effectively reach, acquire and retain additional communities of fans and potential bettors,” said Joe Dunnigan, Founder and CEO of ALT Sports Data. “Receiving this honor highlights the demand for sportsbook operators to drive engagement among large, untapped audiences, and underscores the ability for alternative sports trading data to deliver a significant number of engaged, depositing players.” Previous winners of the Ifrah Pitch Competition include Hedge and Skrmiish. Finalists this year included Sparket and CashComment, in addition to ALT Sports Data. ALT Sports Data has secured official partnerships with several premier leagues within the alternative sports space such as World Surf League, Major Arena Soccer League and Street League Skateboarding among others. About ALT Sports Data ALT Sports Data is the leading source of official and unofficial alternative sports trading data unlocking millions of participatory fans and potential bettors for sportsbook operators, media platforms and event producers. This enables partners to offer real-time dynamic trading data from a robust sports portfolio, and engage with one billion global alternative sports fans. The proprietary trading platform covers the full wagering lifecycle for all offered events. Pre-match and live odds service generates independent, algorithm-driven, and mathematically correct betting markets using dedicated models. Where available, specialist sports seamlessly incorporate in-play betting markets aligned with the enthralling nature of the associated live sports. Contact Details Alex shapiro +1 732-770-9395 ashapiro@hotpaperlantern.com Company Website https://www.altsportsdata.com/

May 05, 2023 10:00 AM Eastern Daylight Time

GBB Drink Lab Files $53M Lawsuit Against FSD Pharma for Nondisclosure Contract Breach and Trade Secret Misappropriation

GBB Drink Lab

GBB Drink Lab (“GBB” or the “Company”), maker of the world’s first formulated drink that aids in rapid blood alcohol detoxification, has announced that the Company has filed a lawsuit against FSD Pharma (NASDAQ: HUGE) (“FSD”), a publicly traded biotechnology company that operates in the pharmaceutical research and development business. As a result of FSD Pharma’s failure to comply with a Cease-and-Desist letter sent by GBB on April 14 th, 2023, the Company has subsequently filed a $53 million complaint for material breach of a mutual nondisclosure agreement and trade secret misappropriation. Filed on May 1 st, 2023, in the U.S. District Court for the Southern District of Florida, the complaint alleges that after seven months of exploring a business opportunity of mutual interest and benefit revolving around GBB’s blood alcohol detoxification drink, FSD Pharma publicly announced the misappropriation of GBB’s trade secrets to current and prospective investors in one of its press releases. In the press release, FSD Pharma discussed the launch of a new research and development program targeting unmet medical needs for alcohol misuse and deliberately omitted the underlying misappropriation. GBB’s lawsuit alleges that FSD Pharma used GBB’s proprietary and confidential material to raise capital, persuade iconic entrepreneurs to join its advisory board, and drive up the price of FSD Pharma’s publicly traded stock. The Company is seeking compensatory and punitive damages as well as an injunction against FSD Pharma preventing further unlawful disclosure and use of the Company’s trade secrets. The lawsuit has been filed in the U.S. District Court for the Southern District of Florida under the name GBB DRINK LAB, INC. v. FSD BIOSCIENCES INC. with case number: 0:23-cv-60800-AHS. GBB has a patented formula that accelerates the process of converting alcohol to sugar in the body. By enhancing the metabolic pathways that facilitate this process, the formula can help the body clear alcohol much faster than normal. The Company has been working on a proprietary drink for several years using its patented formula. About GBB Drink Lab GBB Drink Lab started with a vision of making a positive impact by offering practical, evidence-based solution to reducing Blood Alcohol Content. The company’s product has been meticulously crafted to optimize your ability to sober up thus enabling you to escape an inebriated state. GBB Drink Lab leadership team includes accomplished serial entrepreneurs, a former senior executive from one of the world’s largest beverage companies, and an industry-leading expert in flavoring science and product formulation. For more information, visit https://gbbdrinklab.com/. Media Contact Jarrett Boon Co-Founder, CEO, GBB Drink Lab, Inc Jarrett@gbbdrinklab.com 602-456-1555 Contact Details GBB Drink Lab Jarrett@gbbdrinklab.com Company Website https://gbbdrinklab.com/

May 05, 2023 08:45 AM Eastern Daylight Time

Can Someone Explain the Snail Secretion Skincare Craze?

Caracol Natural Skincare

Caracol Natural Skincare, NEW to the US, is a natural skincare brand that uses snail secretion as the key ingredient. Steeped in tradition, this Chilean based family-owned skincare brand has combined Chilean ancient medicine with modern technology and is now available in the US on AMAZON. Founded in 2006, Caracol Natural is a beautiful story of people in harmony with nature, with high admiration for Chilean and global ancestral medicine, and with the conviction that skincare with natural eco-friendly ingredients, along with premium actives, can offer better-faster-stronger results. The use of snail secretion (also known as snail mucin) in cosmetics can be traced back to ancient Greece, where Hippocrates reportedly prescribed snails for skin inflammation. In the 20th century, snail farmers in Chile noticed that their hands became softer and smoother after handling snails, which led to the development of snail-based creams for hand care. The use of snail secretion in skincare products again gained popularity in the 1990s, when a group of Chilean farmers developed a snail cream that became a best-seller in Korea. Since then, snail secretion has been incorporated into a wide range of skincare products, including creams, serums, masks, and lotions. One of the most interesting aspects of snail secretion is its ability to improve skin health in multiple ways. Snail secretion is a complex mixture of compounds, including hyaluronic acid, glycolic acid, allantoin, antioxidants, and peptides, that can work together to provide a range of benefits for the skin. Another interesting aspect of snail secretion is that it is a natural ingredient that is sustainably sourced. Snail farming is a relatively low-impact agricultural practice that doesn't require large amounts of water or land, making it an environmentally friendly option. Here are some of the main benefits of snail secretion: Hydration: Snail secretion contains hyaluronic acid, glycolic acid, and allantoin, which help to hydrate and moisturize the skin. This can help to reduce the appearance of fine lines and wrinkles, and leave the skin looking plump and supple. Anti-aging: Snail secretion contains antioxidants, peptides, and other compounds that can help to reduce the signs of aging. It may help to improve skin elasticity, reduce the appearance of dark spots, and improve skin texture. Healing: Allantoin, a compound found in snail secretion, has been shown to have wound-healing properties. It may help to reduce inflammation, speed up the healing process, and reduce the risk of scarring. Soothing: Snail secretion has a soothing effect on the skin, which can help to reduce redness and irritation. This makes it particularly beneficial for people with sensitive skin. Brightening: Snail secretion contains glycolic acid, which can help to brighten the skin and reduce the appearance of dark spots and hyperpigmentation. The Caracol Natural lineup includes: The Gentle Cleanser - $22.99 The Gentle Cleanser Facial Foam Expert gently removes impurities while respecting your natural skin barrier. This gentle face wash formula includes Snail Secretion Filtrate plus 8 Clearing Vegetal Extracts like Nettle, Aloe Vera, Sage and Rosemary that helps restore skin balance. Our formula is fitter for sensitive, delicate, dry, flaky, worn, dull, sallow skin, nevertheless is recommended for balancing oily skin and suitable for all skin types The Eye Contour Serum - $32.99 The Eye Contour Serum hydrates, moisturizes, refreshes and restores the healthy appearance of the delicate skin around the eye. It helps to depuff, reduce dark circles and sagginess, lessen oxidative stress, minimize and prevent fine lines and crow's feet. Our Eye Contour Serum helps to brighten, firm, plump, lift, soothe and smooth skin to sustain and recover a radiant, lively and healthier look. The Gentle Serum - $35.99 The Premium Gentle Serum is designed to restore and maintain firmer, denser, flexible, healthier, radiant and bouncier skin. Our Skin Care Gentle Serum for Face and Neck helps subside fine lines, wrinkles, sagginess and dullness. It lessens oxidative stress, it hydrates, moisturizes, softens, calms, plumps, and boosts skin wellbeing, bestowing a beautiful and youthful complexion. Texture Reform Cream - $32.99 The Texture Reform Cream feels soft, silky, light, cool and fresh; it moisturizes and hydrates efficiently without leaving a greasy feeling; it appeals to anyone grease-averse. It helps to brighten up dull and lackluster skin, care for the balance of normal to oily skin, sensitized and acne prone skin (it is not medicinal), lessen oxidative stress, minimize and prevent the appearance of fine lines and wrinkles, keep in check aging and strengthen the skin barrier. Caracol Natural Skincare is NOW available on AMAZON. Contact Details CARACOL NATURAL SKINCARE Dianne Vavra / Spotlight Beauty +1 917-331-4869 Company Website https://caracol-skincare.com/en/

May 04, 2023 09:03 AM Eastern Daylight Time

Image

Auto Parts 4Less Group, Inc. Announces DPI Off-Road Brands™ Has Joined Their Automotive Parts Marketplace, AutoParts4Less.com

Auto Parts 4Less Group Inc

Auto Parts 4Less Group, Inc. (OTCQB: FLES) (“Company”, “FLES”) – the operator of AutoParts4Less.com, a specialized automotive parts marketplace, is pleased to announce that DPI Off-Road Brands™, a leading provider of suspension parts, interior and exterior accessories for trucks, Jeeps, and powersports vehicles, has joined the AutoParts4Less.com multi-seller platform. DPI Off-Road is head quartered in Phoenix, Arizona. DPI Off-Road also operates out of three distribution centers in West Jordan, UT, Denver, CO, and Atlanta, GA. Additionally, DPI Off-Road has a satellite facility in Cedar City, UT. DPI Off-Road Brands™ offers a comprehensive range of top-quality suspension parts and accessories for the light truck and powersports enthusiast at highly competitive prices. With over 150 years of combined experience in the automotive industry, the DPI Off-Road Brands team is committed to staying at the forefront of the aftermarket industry. DPI Off-Road Brands' portfolio includes some of the largest and most trusted brands in the aftermarket parts sector, such as Daystar Products International®, Performance Accessories®, Tuff Country®, Leveling Solutions®, Revtek®, VooDoo Off-Road®, MCE Fenders®, Scorpion Extreme Products®, Nitro Gear & Axle®, HCR Racing®. Together, these well-established brands offer a diverse range of aftermarket products, designed to ensure peak performance during outdoor adventures. Trusted by more than 134,056 customers, DPI Off-Road Brands™ delivers a full range of industry-leading suspension parts, interior and exterior accessories for Jeeps, Trucks, and Powersports vehicles. Christopher Davenport, President at Auto Parts 4Less, Inc., said, "We are extremely excited that DPI Off-Road Brands has chosen to offer their products on our marketplace and trust our technology to power their sales. As we continue to build a trusted marketplace of enterprise-level sellers, we are particularly enthusiastic about welcoming DPI's trusted brands to our platform and the AutoParts4Less B2B ecosystem, which has begun beta testing. Our B2B program is a new initiative that we will be rolling out in the near future where, for example, manufactures can sell direct to repair shops and installation centers”. Matt Reyer, Director of E-commerce at DPI Off-Road Brands, also expressed enthusiasm about the partnership, stating, "We are very excited to be a part of the AutoParts4Less.com marketplace, especially given its focus on the B2B program. This partnership will allow us to better serve our customers and expand our reach in the automotive aftermarket industry." The addition of DPI Off-Road Brands to AutoParts4Less.com further expands the platform's offerings and reinforces its commitment to providing a one-stop-shop for all automotive parts needs. As the marketplace continues to grow, both sellers and buyers will benefit from the diverse range of products and brands available on AutoParts4Less.com. About Auto Parts 4Less Group, Inc. Auto Parts 4Less Group, Inc. (the “Company”) entered the online auto parts business in 2015, selling lift kits and other aftermarket accessories for Jeeps, Trucks, and SUVs on eBay and Amazon. In early 2020, the company began developing AutoParts4Less.com as a multi-seller enterprise-level marketplace dedicated to consolidating the $500 billion annual aftermarket automotive parts industry, including cars, trucks, boats, motorcycles, and RVs, on a single platform. AutoParts4Less.com officially launched with around 2 million parts from over 25 parts sellers in November 2022. For more information about Auto Parts 4Less Group, Inc., please visit AutoParts4LessGroup.com For more information about DPI Off-Road Brands™, please visit www.DPIOffroad.com. Safe Harbor & Disclaimer This information also contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words “could”, “believe”, “anticipate”, “intend”, “estimate”, “expect”, “may”, “continue”, “predict”, “potential”, “possible,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this presentation. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results may differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company’s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Industry data provided herein is of no predictive value regarding the future sale of the Company’s products. No information in this press release should be construed as any indication whatsoever of the Company’s future financial results, revenues, or stock price. For more information, contact: Email: PR@The4LessCorp.com Contact Details Auto Parts 4Less Group, Inc. PR@The4LessCorp.com Company Website https://www.the4lessgroup.com/

May 04, 2023 08:45 AM Eastern Daylight Time